Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥ 5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities

Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥ 5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities

Item
http://www.wikidata.org/entity/Q34453538
Statins for primary prevention of venous thromboembolismStatins for the primary prevention of cardiovascular diseaseStatins for primary prevention of venous thromboembolismPrimary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.Rosuvastatin: a review of the pharmacology and clinical effectiveness in cardiovascular disease.JUPITER and satellites: Clinical implications of the JUPITER study and its secondary analyses.Estimating treatment effects for individual patients based on the results of randomised clinical trials.Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.Metabolic syndrome: nature, therapeutic solutions and options.Initiation of statin therapy: are there age limits?Between risk charts and imaging: how should we stratify cardiovascular risk in clinical practice?[The relevance of biomarkers for personalised medicine].The systematic coronary risk evaluation (SCORE) for the prevention of cardiovascular diseases. Does evidence exist for its effectiveness? A systematic review.Assessment of auditory processing disorder in children using an adaptive filtered speech test.
P2860

Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥ 5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities

Item
http://www.wikidata.org/entity/Q34453538
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Rosuvastatin for primary preve ...... by European health authorities
@ast
Rosuvastatin for primary preve ...... by European health authorities
@en
Rosuvastatin for primary preve ...... by European health authorities
@nl
type
label
Rosuvastatin for primary preve ...... by European health authorities
@ast
Rosuvastatin for primary preve ...... by European health authorities
@en
Rosuvastatin for primary preve ...... by European health authorities
@nl
prefLabel
Rosuvastatin for primary preve ...... by European health authorities
@ast
Rosuvastatin for primary preve ...... by European health authorities
@en
Rosuvastatin for primary preve ...... by European health authorities
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Rosuvastatin for primary preve ...... by European health authorities
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932